Methotrexate-induced cutaneous ulceration in patients with erythrodermic mycosis fungoides

Methotrexate-induced cutaneous ulceration has rarely been reported in patients with mycosis fungoides. We report 4 patients with mycosis fungoides who developed cutaneous ulceration as an initial manifestation of methotrexate toxicity. Methotrexate dose at the time of ulceration ranged from 10–60 mg. All 4 patients were erythrodermic, which may have predisposed them to this toxic effect. It is important to recognize cutaneous ulceration as an uncommon, but potentially serious, side effect of methotrexate in these patients, and to differentiate it from ulceration due to progressive lymphoma.

[1]  L Naldi,et al.  Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks , 2005, The British journal of dermatology.

[2]  M. Kashani-Sabet,et al.  Low-dose methotrexate to treat mycosis fungoides: a retrospective study in 69 patients. , 2003, Journal of the American Academy of Dermatology.

[3]  M. Lebwohl,et al.  Cutaneous ulceration caused by methotrexate. , 2003, Journal of the American Academy of Dermatology.

[4]  T. Jaing,et al.  Toxic epidermal necrolysis following combination of methotrexate and trimethoprim–sulfamethoxazole , 2000, International journal of dermatology.

[5]  D. Ben-Amitai,et al.  Cutaneous Ulceration: An Unusual Sign of Methotrexate Toxicity — First Report in a Patient without Psoriasis , 1998, The Annals of pharmacotherapy.

[6]  C. Camisa,et al.  Methotrexate-induced toxic epidermal necrolysis in a patient with psoriasis. , 1997, Journal of the American Academy of Dermatology.

[7]  B. Wilson,et al.  Erosion of psoriatic plaques: an early sign of methotrexate toxicity. , 1996, Journal of the American Academy of Dermatology.

[8]  M. Kashani-Sabet,et al.  Low-dose methotrexate to treat erythrodermic cutaneous T-cell lymphoma: results in twenty-nine patients. , 1996, Journal of the American Academy of Dermatology.

[9]  C. Gisselbrecht,et al.  Décollements cutanés induits par le méthotrexate , 1992 .

[10]  E. Olsen.  The pharmacology of methotrexate. , 1991, Journal of the American Academy of Dermatology.

[11]  E. Epstein,et al.  Low-dose methotrexate for the Sézary syndrome. , 1989, Journal of the American Academy of Dermatology.

[12]  E. Olsen,et al.  Erosion of Psoriatic Plaques After Chronic Methotrexate Administration , 1988, International journal of dermatology.

[13]  C. Lawrence,et al.  Two patterns of skin ulceration induced by methotrexate in patients with psoriasis. , 1984, Journal of the American Academy of Dermatology.

[14]  A. Sober,et al.  Methotrexate-induced necrolysis. , 1983, Journal of the American Academy of Dermatology.

[15]  J. Bertino,et al.  Treatment of mycosis fungoides lymphoma: effectiveness of infusions of methotrexate followed by oral citrovorum factor. , 1978, Cancer treatment reports.

[16]  H. Baker.  INTERMITTENT HIGH DOSE ORAL METHOTREXATE THERAPY IN PSORIASIS * , 1970, The British journal of dermatology.